Observed Signal · Oct 13, 2026 · Partnership · Source: PR Newswire: Technology News · Impact: 1/5 · Sentiment: Positive
IQVIA Expands Veeva Partnership with Clinical Operations Applications
IQVIA and Veeva Systems announced an expansion of their partnership, with IQVIA selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications for its clinical development studies. This extends the previously announced EDC partnership. The collaboration aims to increase trial speed and efficiency, strengthen site centricity, and improve decision-making for clinical research customers. All Veeva clinical solutions will also be available through IQVIA for sponsors seeking a full Veeva technology stack. Executives from both companies emphasized the benefits of integrated technologies and customer flexibility in choosing EDC, RTSM, and eCOA solutions. The announcement was made on October 13, 2026, ahead of the Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.
The partnership between IQVIA and Veeva is a significant enterprise software deal in the life sciences industry, but it is not directly relevant to the AdTech/MarTech ecosystem, so its importance to that industry is minimal.
Track Veeva Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- IQVIA selected Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications.
- Partnership expansion extends the previously announced EDC partnership.
- All Veeva clinical solutions will be available through IQVIA for sponsors.
- Announcement made on October 13, 2026.
- Veeva R&D and Quality Summit scheduled for October 20-21 in Boston.
Connected Companies & Entities
1 Entity mapped“Veeva Systems announced an expansion of their partnership with IQVIA for clinical development studies.”
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Eli Lilly Selects Veeva Vault CRM Globally
Veeva Systems announced that Eli Lilly and Company has committed to Veeva Vault CRM for global deployment. Vault CRM, part of Veeva's Vault CRM Suite, is described as the technology foundation for “agentic commercial,” a commercial model that leverages AI to deliver medicines to patients. Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly, and Veeva CEO Peter Gassner are quoted on the strategic expansion. Veeva is described as an industry cloud provider for life sciences serving more than 1,500 customers and operating as a Public Benefit Corporation. The announcement was distributed via PR Newswire and published on MarTech Series on August 11, 2026.
10-Q Financial Filing Analysis for Veeva (2026-08-27)
Veeva Systems Inc. reported strong financial results for the second quarter of fiscal year 2027 ended July 31, 2026, with total revenue rising 18% year-over-year to $927.96 million. Top-line expansion was driven by a 16% increase in core subscription revenues to $766.76 million alongside a 24% rise in professional services to $161.20 million, driving GAAP operating income up to $275.02 million from $195.91 million in Q2 FY2026. Operationally, Veeva advanced its major migration of CRM customers from Salesforce to its proprietary Vault CRM platform (supported through 2029) and integrated Rise Healthcare Tech (Ostro), an AI-driven engagement platform acquired for $90 million, while deploying $246 million toward share repurchases.
New Veeva Study Builder Agent to Configure Clinical Studies in as Little as One Day
Veeva announces a new Study Builder Agent that can configure clinical studies in as little as one day, along with other updates including another Top 20 biopharma choosing Vault CRM and the introduction of Falcon Router for agentic triage.
Receive all future signals for Veeva & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.